Categories AlphaGraphs, Earnings, Retail

TGT Earnings: All you need to know about Target’s Q4 2023 earnings results

Target Corporation (NYSE: TGT) reported fourth quarter 2023 earnings results today.

Total revenue was $31.9 billion, up 1.7% compared to the same period last year. Comparable sales declined 4.4%.

Net earnings grew 58% to $1.38 billion, or $2.98 per share, compared to last year. Adjusted EPS rose 58% to $2.98.

Both the top and bottom line numbers beat expectations, sending the stock soaring over 9% in premarket hours on Tuesday.   

For the first quarter of 2024, the company expects a comparable sales decline of 3-5%. GAAP and adjusted EPS are both expected to range between $1.70-2.10.

For the full year of 2024, Target expects comparable sales to range from flat to up 2%. GAAP EPS and adjusted EPS are both expected to range between $8.60-9.60.

Prior performance

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top